These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34643655)

  • 41. Halocynthiaxanthin and peridinin sensitize colon cancer cell lines to tumor necrosis factor-related apoptosis-inducing ligand.
    Yoshida T; Maoka T; Das SK; Kanazawa K; Horinaka M; Wakada M; Satomi Y; Nishino H; Sakai T
    Mol Cancer Res; 2007 Jun; 5(6):615-25. PubMed ID: 17579120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Jekyll & Hyde: The Other Life of the Death Ligand TRAIL.
    Lalaoui N; Silke J
    Mol Cell; 2017 Feb; 65(4):585-587. PubMed ID: 28212746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activated Cdc42-associated kinase 1 (Ack1) is required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor recruitment to lipid rafts and induction of cell death.
    Linderoth E; Pilia G; Mahajan NP; Ferby I
    J Biol Chem; 2013 Nov; 288(46):32922-31. PubMed ID: 24085293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The long and winding road to cancer treatment: the TRAIL system.
    Palacios C; Yerbes R; Sanchez-Perez T; Martin-Perez R; Cano-Gonzalez A; Lopez-Rivas A
    Curr Pharm Des; 2014; 20(17):2819-33. PubMed ID: 23944369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies.
    Holoch PA; Griffith TS
    Eur J Pharmacol; 2009 Dec; 625(1-3):63-72. PubMed ID: 19836385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peroxiredoxin 6 interferes with TRAIL-induced death-inducing signaling complex formation by binding to death effector domain caspase.
    Choi H; Chang JW; Jung YK
    Cell Death Differ; 2011 Mar; 18(3):405-14. PubMed ID: 20829884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells.
    Song JH; Tse MC; Bellail A; Phuphanich S; Khuri F; Kneteman NM; Hao C
    Cancer Res; 2007 Jul; 67(14):6946-55. PubMed ID: 17638906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts.
    Kuang AA; Diehl GE; Zhang J; Winoto A
    J Biol Chem; 2000 Aug; 275(33):25065-8. PubMed ID: 10862756
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New insights into apoptosis signaling by Apo2L/TRAIL.
    Gonzalvez F; Ashkenazi A
    Oncogene; 2010 Aug; 29(34):4752-65. PubMed ID: 20531300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
    Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P
    J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex.
    Kavuri SM; Geserick P; Berg D; Dimitrova DP; Feoktistova M; Siegmund D; Gollnick H; Neumann M; Wajant H; Leverkus M
    J Biol Chem; 2011 May; 286(19):16631-46. PubMed ID: 21454681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
    Seol DW; Li J; Seol MH; Park SY; Talanian RV; Billiar TR
    Cancer Res; 2001 Feb; 61(3):1138-43. PubMed ID: 11221844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes.
    Wachter T; Sprick M; Hausmann D; Kerstan A; McPherson K; Stassi G; Bröcker EB; Walczak H; Leverkus M
    J Biol Chem; 2004 Dec; 279(51):52824-34. PubMed ID: 15459191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma.
    Bellail AC; Olson JJ; Yang X; Chen ZJ; Hao C
    Cancer Discov; 2012 Feb; 2(2):140-55. PubMed ID: 22585859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The hepatitis B virus protein MHBs(t) sensitizes hepatoma cells to TRAIL-induced apoptosis through ERK2.
    Liang X; Du J; Liu Y; Cui M; Ma C; Han L; Qu Z; Zhang Z; Sun Z; Zhang L; Chen YH; Sun W
    Apoptosis; 2007 Oct; 12(10):1827-36. PubMed ID: 17701086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling and cell death in the immature central nervous system after hypoxia-ischemia and inflammation.
    Kichev A; Rousset CI; Baburamani AA; Levison SW; Wood TL; Gressens P; Thornton C; Hagberg H
    J Biol Chem; 2014 Mar; 289(13):9430-9. PubMed ID: 24509861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5.
    Li Y; Fan X; Goodwin CR; Laterra J; Xia S
    BMC Cancer; 2008 Nov; 8():325. PubMed ID: 18992144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Developing TRAIL/TRAIL death receptor-based cancer therapies.
    Yuan X; Gajan A; Chu Q; Xiong H; Wu K; Wu GS
    Cancer Metastasis Rev; 2018 Dec; 37(4):733-748. PubMed ID: 29541897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteasome inhibition can impair caspase-8 activation upon submaximal stimulation of apoptotic tumor necrosis factor-related apoptosis inducing ligand (TRAIL) signaling.
    Laussmann MA; Passante E; Hellwig CT; Tomiczek B; Flanagan L; Prehn JH; Huber HJ; Rehm M
    J Biol Chem; 2012 Apr; 287(18):14402-11. PubMed ID: 22408249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand.
    Varfolomeev E; Maecker H; Sharp D; Lawrence D; Renz M; Vucic D; Ashkenazi A
    J Biol Chem; 2005 Dec; 280(49):40599-608. PubMed ID: 16227629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.